Mycoplasma pneumoniae infection in Cuban patients with COVID-19
Keywords:
Mycoplasma pneumoniae; SARS-CoV-2; coinfection.Abstract
Introduction: Coinfection with SARS-CoV-2 (Severe Acute Respiratory Syndrome Coronavirus 2) and Mycoplasma pneumoniae may be a significant factor in the clinical course of COVID-19 (Coronavirus Disease 2019). While bacterial coinfection has been reported in Cuban patients with COVID-19, the occurrence of coinfection with Mycoplasma pneumoniae remains unknown.
Objective: To describe the frequency of Mycoplasma pneumoniae in patients with SARS-CoV-2 infection.
Methods: A descriptive study was conducted to detect Mycoplasma pneumoniae using real-time polymerase chain reaction (PCR) on 200 clinical pharyngeal swab samples from patients with COVID-19.
Results: A positivity rate of 1.5% (3/200) for Mycoplasma pneumoniae was found in the analyzed samples; one case involved a male patient and two involved female patients, with ages ranging from 19 to 59 years.
Conclusions: The detection of Mycoplasma pneumoniae in adult patients with SARS-CoV-2 infection, albeit at a low frequency, suggests the presence of this pathogen as a secondary infection in patients with COVID-19.
Downloads
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Maria Fernanda Barzaga Valdés, Yenis Ramírez Cintra, Nadia María Rodriguez Preval
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Licencia Creative Commons
La Revista Cubana de Medicina Tropcial se encuentra bajo una
Este sitio está bajo Licencia de Creative Commons Reconocimiento-NoComercial 4.0 Internacional.
